In Conversation With... Our Advanced Therapies Week 2023 Speakers

Gene Editing: Tools and Technology of the Future

For this interview, Phacilitate’s Becky Johnson-Kent speaks with Jian Irish, President and COO of Metagenomi about her upcoming Chairing of the session ‘Editing the Future: Gene Editing Tools and Technology’, at Advanced Therapies Week 2023.

11th Jan 2023

LEARN MORE

Tools and Resources for Addressing Evolving Challenges for Cell & Gene Therapy Biotechs

Debra BenAvram explains some of the biggest challenges facing members of the biotherapies community, and how AABB is working to support biotechs with resources.

9th Jan 2023

LEARN MORE

The Impact of AI & Sensor-Based Cell Manufacturing on Price & Availability of Cell Therapy

In this interview, Ohad Karnieli, Founder and CEO of ADVA Biotechnology, explains the different areas AI & sensing can have an impact within the realm of cell therapy, paying special attention to the effect on price and availability of cell therapies.

9th Jan 2023

LEARN MORE

Keeping Up with the Pace in a Rapidly Changing Industry: Innovative Solutions for Cell and Gene Therapy Developers

Edwin Stone, CEO of CellularOrigins, a TTP Company, describes the importance of a smooth clinical to commercial translation and how implementing innovative tools and technologies can support this.

22nd Dec 2022

LEARN MORE

Early Considerations for Commercial Success

For this interview, Phacilitate’s Becky Johnson-Kent speaks with Serene Forte, Senior Vice President, Head of Genetic Medicine at Relief Theraputics, about the tools and techniques required to advance the commercialisation of advanced therapies, as she prepares to Chair the session ‘ Commercializing Gene Therapies : Building Your Strategy From Translation Through to Commercial’ at Advanced Therapies Week 2023.

4th Jan 2023

LEARN MORE

Lessons in Commercial Success

For this interview, Phacilitate’s Becky-Johnson Kent speaks with Cintia Piccina, CCO of AdaptImmune, about what to expect from her role as a panellist in the session ‘Cell Therapy Commercial Success, Overcoming Pitfalls and What We Have Learned from 2022′, at Advanced Therapies Week 2023.

4th Jan 2023

LEARN MORE

Genome Editing Tools and Techniques for Cancer Therapies

For this interview, Phacilitate’s Ryan Leahy speaks with Steve Kanner, CSO Caribou Biosciences, about the tools and techniques Caribou are utilizing in their gene edited T cell and iPCS-cell investigational products, ahead of chairing the session ‘CAR-T Therapies: 10 Years On and the Future of CAR-T’ at Advanced Therapies Week 2023.

3rd Jan 2023

LEARN MORE

BACS™ Microbubbles: The Solution to Better Cell Separation

In this interview, Brandon McNaughton, CEO and Co-Founder of Akadeum Life Sciences, explains the story of innovation for the application of microbubbles in cell therapy manufacturing, and the impact innovation can have on the future of healthcare.

21st Dec 2022

LEARN MORE

Innovating Solutions to Cell Therapy Processing Workflow Challenges

Brian Hanrahan, Vice President of Cell Therapy Commercialization at Planet Innovation, describes the different challenges associated with cell therapy processing workflows before exploring innovative solutions.

19th Dec 2022

LEARN MORE

Improving Novel Theraputics and Early-Phase Trials

For this interview, Phacilitate’s Ryan Leahy speaks with Marc Wolfgang Vice President of Technical Operations for BioNTech U.S, about what to expect from his presentation ‘AAV Platform Process: Continuous Improvement for First in Human Studies’, at Advanced Therapies Week 2023.

5th Dec 2022

LEARN MORE

Commercial Considerations in the World of Rare Diseases

For this interview, Phacilitate’s Becky Johnson-Kent speaks with Emily Chee, General Managers, Americas, at Novartis Gene Therapies, about what to expect from her presentation ‘Lessons learned from Zolgensma’ in the session, ‘Commercializing Gene Therapies: Building Your Strategy From Translation Through to Commercial’ at Advanced Therapies Week 2023

5th Dec 2022

LEARN MORE

Ushering in a New Paradigm for Treatment with ‘Tissue Therapeutics’

In this bite-size interview, Phacilitate’s Ryan Leahy speaks to David Lennon (CEO, Satellite Bio) about what to expect from his session, ‘Tissue and Stem Cell Therapeutics: Breakthroughs for Regenerative Medicine’ at Advanced Therapies Week 2023.

5th Dec 2022

LEARN MORE

“Endowing Cells with Super-Physical Properties” to Better Treat Patient Populations

For this interview, Phacilitate’s Ryan Leahy speaks with David Sourdive Ph.D., Executive Vice President of CMC and Manufacturing, Cellectis, about what to expect from his session, ‘Is cGMP Enough? Operational Excellence for Advanced Medicines’ at Advanced Therapies Week 2023.

29th Nov 2022

LEARN MORE

The Advanced Therapies Workforce Evolution

For this interview, Phacilitate’s Becky Johnson-Kent speaks with Angela Justice (Cheif People Officer, TCR2) about what to expect from the session Angela is to Chair, ‘People Behind the Cures: Recruitment, Opportunity and Diversity for the CGT Workforce’ at Advanced Therapies Week 2023.

29th Nov 2022

LEARN MORE

Creative Mechanisms for Growing the Biomanufacturing Industry

Jenny Ligon, Associate Director of Workforce Development at the National Center for Therapeutic Manufacturing (NCTM), Texas U.S., sat down to talk with Phacilitate’s Editor Georgi Makin to ahead of her appearance and presentation at Advanced Therapies Week 2023.

29th Nov 2022

LEARN MORE

The New Age of Oncology Treatment and the Patient Experience

Courtney Horvath, Global Head of Strategy, Planning and Operations, Translational Medicine at Novartis (NIBR), sat down to talk with Phacilitate’s Editor Georgi Makin to ahead of her appearance and presentation at Advanced Therapies Week 2023.

28th Nov 2022

LEARN MORE

Advancing Cell and Gene Therapies in Rare Diseases: Angelman Syndrome

Allyson Berent, The Foundation for Angelman Syndrome Therapeutics (FAST) CSO, sat down to share the Foundation’s story ahead of her appearance as a confirmed speaker at Phacilitate’s Advanced Therapies Week 2023.

28th Nov 2022

LEARN MORE

Harnessing the Biological Power of Cells to Deliver a Therapeutic Product

For this interview, Phacilitate’s Ryan Leahy speaks with Miguel Forte (President-Elect, ISCT) about what to expect from his session, ‘Decentralizing Advanced Therapies: Are We Moving Closer to Bedside Therapeutics?’ at Advanced Therapies Week 2023.

22nd Nov 2022

LEARN MORE

In Conversation With…

Our Advanced Therapies Week 2023 Speakers